Clinical Trial Software
Total Trials
23
As Lead Sponsor
1
As Collaborator
22
Total Enrollment
25,127
NCT01110460
Prospective Study on Asthma Control
Phase: N/A
Role: Collaborator
Start: Jan 31, 2009
Completion: Nov 30, 2010
NCT00982111
First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin
Phase: Phase 3
Start: Nov 2, 2009
Completion: Dec 23, 2020
NCT01007032
A Study of IMC-A12 in Advanced Solid Tumors
Phase: Phase 1
Start: Nov 30, 2009
Completion: Apr 30, 2015
NCT00981058
First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin
Start: Jan 7, 2010
Completion: May 30, 2024
NCT01138995
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Start: May 31, 2010
Completion: Feb 28, 2013
NCT01133327
Adapt Monorail Carotid Stent System: A Postmarket Clinical Follow-up Study
Start: Jun 30, 2010
Completion: Jun 30, 2012
NCT01148329
PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study
Completion: Dec 31, 2016
NCT01651455
Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000
Start: Sep 30, 2012
Completion: Jun 30, 2013
NCT01787799
EVOLVE II QCA: A Prospective, Multicenter Trial to Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Start: Mar 31, 2013
Completion: Oct 31, 2014
NCT02227303
A Pilot Open Label Clinical Trial to Evaluate the Combined Impact of Two Mobile Health Products on Health Outcomes in Overweight Adults With Type 2 Diabetes
Role: Lead Sponsor
Start: Aug 31, 2014
Completion: Mar 31, 2015
NCT02586155
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
Start: Nov 30, 2015
Completion: Jun 21, 2021
NCT02589236
Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation
Phase: Phase 2
NCT02697916
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Start: Apr 30, 2016
Completion: Jun 30, 2020
NCT03714815
A Long Term Study to Find Out if Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
Start: Dec 7, 2018
Completion: Oct 12, 2021
NCT03775421
An Upcoming Clinical Study to Measure the Safety and Impact of a Drug Called Macitentan in Teenage and Adult Fontan Patients.
Start: Apr 11, 2019
Completion: Jan 18, 2022
NCT04078152
Durvalumab Long-Term Safety and Efficacy Study
Phase: Phase 4
Start: Sep 5, 2019
Completion: Oct 31, 2024
NCT04201132
Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System
Start: Jun 12, 2020
Completion: Dec 31, 2025
NCT04699643
FGFR4 Inhibitor EVER4010001 in Combination With PD-1 Inhibitor Pembrolizumab in Patients With Advanced Solid Tumors
Phase: Phase 1/2
Start: Jul 30, 2020
Completion: Jun 30, 2023
NCT04566653
Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease and Hyperkalaemia
Start: Oct 23, 2020
Completion: Jan 12, 2022
NCT04763512
Clinical Study of Partially Hydrolysed Protein Infant Formula on Trans-epidermal Water Loss (TEWL)
Start: Jun 6, 2021
Completion: Nov 2, 2024
NCT05054309
A Trial to Evaluate the Effects of Bifidobacterium Longum NCC3001 on Intestinal and Psychological Symptoms in Subjects With Irritable Bowel Syndrome
Start: Feb 11, 2022
Completion: Feb 14, 2025
NCT05267613
Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.
Start: Jul 1, 2022
Completion: Sep 6, 2027
NCT06639828
Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver Imaging
Start: Jan 20, 2025
Completion: Oct 31, 2026
Loading map...